The round was led by Atlantic Blue Ventures, S3 Ventures, and Olympus Innovation Ventures with strong participation from our existing investor, Hillside Capital. Funds will be used to grow the team and advance the company's clinical program.

MaxQ Medical is a health-tech company based in Sunnyvale, California developing a fully automated, urethra-preserving, outpatient ultrasound imaging and targeted therapy system for prostate care. The platform is designed to give urologists complete visibility of the prostate and the ability to deliver individualized treatment in a single procedure, starting with BPH and expanding into prostate cancer focal therapy and prostate diagnostics. The MaxQ System is investigational and is not currently available for commercial use in the United States.